OASMIA: OASMIA PHARMACEUTICAL AB (PUBL) PLANS TRANSFER TO OFFICIAL LISTING

Uppsala, SWEDEN


Oasmia has been listed on the NGM Nordic MTF since 30th December 2005. Based on
the company's strong growth and development, along with requests from both
institutional and private investors, Oasmia is now initiating a transfer to an
official listing. The company will during the coming months evaluate
alternatives, and provide a final decision regarding the future listing in
March 2007. 

For more information, contact:

Oasmia Pharmaceutical AB, +46 18 505440 or info@oasmia.com


Oasmia Pharmaceutical (publ) is a pharmaceutical company based on the latest
concepts in bio-organic chemistry. The company idea is to improve treatment of
serious conditions, with a focus on oncology. This is done through development
of semi-synthesised substances to a new generation of effective pharmaceuticals
for various areas of therapy. Oasmia is noted on the NGM Nordic MTF. More
information is available at www.ngm.se or at www.oasmia.com. 

Attachments

file24.pdf